Donal OShea

Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.

Part of Zoetis, Inc., BioNua Ltd. is a company headquartered in Ireland that develops and manufactures biopharmaceuticals in the field of veterinary biologic therapies.

M&G Wealth Investment LLP (M&G Wealth) is an asset management firm headquartered in London, UK. Formerly TCF Fund Managers LLP, the firm was founded by Dan Norman and Gary Mairs in 2003 as Rutherglen Capital LLP. They were acquired by M&G Plc (LON: MNG; OTCMKTS: MGPUF) in 2022. M&G Wealth provides a variety of investment solutions to their clients.

Artefact Partners LLP is the hedge fund management subsidiary of Artefact Partners (Holding) Ltd. in Great Britain. The firm was founded by Richard Boon and Damian O'Brien in 2005. Headquartered in Wallington, Artefact Partners manages the assets of high-net-worth clients.

Part of Baxter International, Inc., Baxter Healthcare Ltd. is a company based in Newbury, UK. Baxter Healthcare Ltd. helps maximize safety, streamline processes, and build cost efficiency throughout the hospital, from the pharmacy to the bedside. The British company was founded in 1948. José E. Almeida has been the CEO of the company since 2016.

The Irish Cancer Society funds various types of cancer research and provides resources such as booklets, leaflets, factsheets, and posters to inform individuals on how to reduce their risk of developing cancer. The location of the Irish Cancer Society is in Ballsbridge, Ireland. Additionally, the organization is examining the financial challenges faced by young cancer patients and their loved ones during treatment.

Part of Advanced Medical Solutions Group Plc, Connexicon Medical Ltd. is an Irish company that manufactures and wholesales tissue adhesives and sealants. The company is based in Dublin, Ireland. The company was founded by Padraig Leamy. Padraig Leamy has been the CEO since incorporation. Connexicon Medical was acquired by Advanced Medical Solutions Group Plc on February 01, 2023 for $27.15 million.

Part of DiaSorin SpA, DiaSorin Ireland Ltd. develops, manufactures, and sells leading diagnostic tests for the identification of diseases and important life science products. The company is based in Blackrock, Ireland. The CEO of the Irish company is Cormac G. Kilty. DiaSorin Ireland was acquired by DiaSorin SpA on July 09, 2008 for $39.20 million.

Stonehaven Incubate AG provides investment services in animal health sector. The company is headquartered in Andermatt, Switzerland.

Dipexium Pharmaceuticals Ireland Ltd. provides professional, scientific, and technical services.

Baxter Healthcare SA engages in the development, production, and sale of healthcare systems and products. It also acquires and manages participations in pharmaceutical-chemical firms. The company was founded on December 7, 2000 and is headquartered in Glattpark, Switzerland.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia.

Part of EKF Diagnostics Holdings Plc, Argutus Medical Ltd. develops and manufactures novel organ injury test and urinary biomarkers for the healthcare industry. The company is based in Dublin, Ireland. The Irish company was founded by Cormac G. Kilty. Argutus Medical was acquired by EKF Diagnostics Holdings Plc on December 02, 2010 for $3.67 million.

SSG Private Debt Rated Notes II LP engages in pooled investment fund industry. The company is headquartered in Wilmington, DE.